Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 4, multicenter, prospective, observational two-part 3-Year Longitudinal Registry and study of AUSTEDO (deutetrabenazine) for tardive dyskinesia (TD)

Next Previous
X
Search
Trial Profile

Phase 4, multicenter, prospective, observational two-part 3-Year Longitudinal Registry and study of AUSTEDO (deutetrabenazine) for tardive dyskinesia (TD)

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Deutetrabenazine (Primary)
  • Indications Drug-induced dyskinesia
  • Focus Therapeutic Use

    • Most Recent Events

    • 01 Nov 2024 According to a Teva Pharmaceuticals media release, interim data from a patient-reported survey describing early, real-world experience with AUSTEDO XR are being presented at the Psych Congress 2024 taking place from October 29 -November 2 in Boston, MA.
    • 01 Jun 2024 Interim results from this trial presented in a Teva Pharmaceuticals media release.
    • 01 Jun 2024 According to a Teva Pharmaceuticals media release, new patient- and physician-reported interim results from this Phase 4 IMPACT-TD Registry study, reinforcing that TD has a wide-reaching, multidimensional impact on patients quality of life, were presented at the 2024 Psych Congress Elevate Annual Meeting, taking place from May 30 - June 2 in Las Vegas, Nevada.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top